Alignment Healthcare (ALHC) director granted 13,096 restricted stock units

Rhea-AI Filing Summary

JORDEN YON reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare director Jorden Yon received a new equity grant. The filing shows an award of 13,096 restricted stock units of Alignment Healthcare, Inc. common stock, with no cash paid per share. After this grant, Yon directly holds 105,830 shares or share equivalents.

Each of the 13,096 restricted stock units represents a right to receive one share of common stock. The entire grant will vest on the one-year anniversary of the grant date, as long as Yon continues serving on the Board of Directors through that date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider JORDEN YON

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13,096	$0.00	--

Holdings After Transaction: Common Stock — 105,830 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JORDEN YON

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		13,096(1)	A	$0	105,830	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Yon Jorden	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alignment Healthcare (ALHC) director Jorden Yon report in this Form 4?

Director Jorden Yon reported receiving 13,096 restricted stock units of Alignment Healthcare common stock. These units are a form of equity compensation and do not involve an open-market purchase or sale, but rather an award that may convert into shares if vesting conditions are met.

How many Alignment Healthcare (ALHC) shares does Jorden Yon hold after this transaction?

After the award, Jorden Yon directly holds 105,830 shares or share equivalents of Alignment Healthcare common stock. This figure includes the newly granted 13,096 restricted stock units, which will become actual shares only if they vest under the specified service condition.

What are the vesting terms of Jorden Yon's 13,096 restricted stock units in ALHC?

All 13,096 restricted stock units will vest on the one-year anniversary of the grant date, provided Yon continues to serve as a member of the Board of Directors until that date. If board service ends earlier, unvested units may be forfeited under the award terms.

Was there any cash transaction involved in Jorden Yon's recent ALHC stock award?

No cash changed hands in this award. The 13,096 restricted stock units were granted at a stated price of $0.00 per unit, reflecting equity compensation rather than a market purchase. The units represent future rights to shares, subject to vesting requirements.

Does this ALHC Form 4 indicate Jorden Yon bought or sold shares on the open market?

The filing does not show any open-market buying or selling. It records a grant of 13,096 restricted stock units as compensation, classified as a “grant, award, or other acquisition,” which increases Yon's equity exposure without a traditional stock trade.